Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Operating Leases (2025 - 2026)

BioAge Labs' Operating Leases history spans 1 years, with the latest figure at $2.3 million for Q4 2025.

  • On a quarterly basis, Operating Leases changed N/A to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a N/A change, with the full-year FY2025 number at $2.3 million, changed N/A from a year prior.
  • Operating Leases hit $2.3 million in Q4 2025 for BioAge Labs, down from $2.4 million in the prior quarter.
  • Over the last five years, Operating Leases for BIOA hit a ceiling of $2.6 million in Q1 2025 and a floor of $2.3 million in Q4 2025.